Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−6.91 MUSD
3.57 M
Om Galmed Pharmaceuticals Ltd.
Sektor
Bransch
VD
Allen Baharaff
Webbplats
Huvudkvarter
Ramat Gan
Employees (FY)
8
Grundat
2000
ISIN
IL0011313900
FIGI
BBG005ZD02W1
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
